Stop TB Partnership
- Johnson & Johnson is allowing Stop TB Partnership, a Switzerland-based nonprofit, to distribute a generic version of its tuberculosis drug SIRTURO, or bedaquiline, in low- and middle-income countries.
- The Stop TB Partnership was founded in 2001 to eliminate tuberculosis as a public health problem.
- It has been administered by the United Nations Office for Project Services (UNOPS).
- The Stop TB Partnership brings together expertise from a broad spectrum of countries, regional and global partners in their shared mission to revolutionize the TB space and end TB by ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here